Clinical Trial Update: Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial at St. Jude evaluating the combination of venetoclax and navitoclax for relapsed or refractory acute lymphoblastic leukemia; the study is acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Navitoclax (navitoclax)
• Venetoclax (venetoclax)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Refractory Acute Lymphoblastic Leukemia, Relapsed Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-09-22